ZIMVV ZIMVIE INC

ZimVie Announces the Release of RealGUIDE® 5.4 Software Update

ZimVie Announces the Release of RealGUIDE® 5.4 Software Update

Latest Update for ZimVie’s RealGUIDE® Dental Implant Software Suite Introduces New Features to Drive Provider Efficiency and Savings

PALM BEACH GARDENS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced the release of its RealGUIDE® 5.4 software. The update is now available in all markets where RealGUIDE is sold, enhancing ZimVie’s current RealGUIDE software suite for treatment planning and implant restoration.

RealGUIDE 5.4 now helps users manage procedural risk more effectively and plan complex cases in a fraction of the time. The most significant enhancement in this version is one-click nerve detection and automated bone and tooth segmentation. This empowers clinicians with greater case insights and treatment planning confidence, as well as significant time savings. Additionally, RealGUIDE 5.4 introduces new restorative design workflows meeting the evolving needs of the most demanding clinics and dental laboratories. New amplified CAD workflows empower labs to create the most attractive designs in implant dentistry. Now with an automated 'split-bar' toolset, this new feature makes the creation of complex multi-material prostheses for full-mouth rehabilitation intuitive and efficient. Additionally, new cloud-based design libraries offer improved accessibility for the restorative professional.

“This most recent version of RealGUIDE software underscores ZimVie’s commitment to innovation and empowers healthcare providers to deliver exceptional dental care with greater efficiency, safety, and esthetic outcomes, thereby lowering the cost and improving the quality of implant dentistry,” said Vafa Jamali, President and Chief Executive Officer, ZimVie. “Our goal is to drive guided surgery to be the standard of excellence for all implant cases and subsequently drive greater adoption of implant dentistry.”

        

About RealGUIDE

RealGUIDE is a software suite that offers precise planning, designing, and predictable placement of dental implants and restorations. It consists of several software modules that may be combined as desired for a thorough diagnosis, intended implant positioning, advanced surgical guide design, and cutting-edge restorative design and manufacturing. For more information, please visit the website.

About ZimVie

ZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.

Media Contact Information:

ZimVie

Allison Johnson • (774) 266-8046

ZimVie

Grace Flowers •

(561) 319-6130

Investor Contact Information:

Gilmartin Group LLC

Marissa Bych •



EN
31/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE

ZimVie Announces Completion of its Acquisition by ARCHIMED

ZimVie Announces Completion of its Acquisition by ARCHIMED ZimVie Inc. Becomes Privately Held Company PALM BEACH GARDENS, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental implant market, today announced that ARCHIMED, an investment firm focused exclusively on healthcare industries, has completed its previously announced acquisition of ZimVie. Pursuant to the terms of the transaction announced on July 20, 2025, ARCHIMED acquired all of the outstanding shares of ZimVie stock. ZimVie stockholders are entitled to receive $19.00 in ...

 PRESS RELEASE

ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED

ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the “Merger”) pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 20, 2025 (the “Merger Agreement”). The parties now expect the Merger to close on October 20, 2025, subject to the satisfaction of all conditio...

 PRESS RELEASE

ZimVie Reports Second Quarter 2025 Financial Results

ZimVie Reports Second Quarter 2025 Financial Results Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per shareNet Sales from Continuing Operations of $116.7 millionNet Loss from Continuing Operations of $(3.8) million; Net Loss margin of (3.3)% Adjusted EBITDA[1] from Continuing Operations of $17.5 million; Adjusted EBITDA[1] margin of 15.0%GAAP diluted EPS from Continuing Operations of $(0.14) and adjusted diluted EPS[1] from Continuing Operations of $0.26 PALM BEACH GARDENS, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a g...

 PRESS RELEASE

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 202...

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 PALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July 30, 2025. On July 21, 2025, ZimVie issued a press release announcing ZimVie’s entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”) for $19.00 in cash pe...

 PRESS RELEASE

ZimVie Announces Exclusive Distribution Agreement with Osstem Implant ...

ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China Strategic Partnership Provides Market Presence in Growing Chinese Market PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd. (“Osstem Implant”), a leading dental solutions provider specializing in high-quality implants and integrated dental technologies globally. The agreement expands ZimVie’s ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch